 |
Here's where you'll find the latest news on our company and its
research and development projects.
Latest News:
GENELABS TECHNOLOGIES ANNOUNCES PRESENTATION OF
DATA ON HCV NS4B INHIBITORS AT THE INAUGURAL HCV DRUG DISCOVERY
MEETING
REDWOOD CITY, Calif., April 30, 2008 - Genelabs Technologies,
Inc. (Nasdaq:GNLB) announced today that a presentation was made at
the Inaugural HCV Drug Discovery meeting being held in La Jolla,
California, providing information about Genelabs' first-in-class
program targeting a novel antiviral mechanism for treating hepatitis
C virus (HCV).
The oral presentation was given by
Christopher D. Roberts, Ph.D., Senior Director of Medicinal
Chemistry at Genelabs, entitled “Targeting HCV NS4b Function: A
New Approach to Anti-HCV Activity”
Read more... |
|
